Jaguar Health, INC. (JAGX) — DEF 14A Filings

All DEF 14A filings from Jaguar Health, INC.. Browse 5 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (5)

Jaguar Health Seeks Shareholder Nod for Key Equity Issuances — Nov 10, 2025 Risk: high
Jaguar Health, Inc. (JAGX) is convening a Special Meeting of Stockholders on December 8, 2025, to seek approval for two critical proposals under Nasdaq Listing
Jaguar Health Details Executive Equity Awards, Compensation Structure — Jul 21, 2025 Risk: medium
Jaguar Health, Inc. (JAGX) filed its DEF 14A on July 21, 2025, outlining executive compensation and governance matters for the fiscal year ended December 31, 20
Jaguar Health Files Definitive Proxy Statement — Feb 24, 2025 Risk: low
Jaguar Health, Inc. filed a definitive proxy statement (DEF 14A) on February 24, 2025, for its annual meeting of stockholders. The filing concerns the solicitat
Jaguar Health Files Definitive Proxy Statement — May 21, 2024 Risk: low
Jaguar Health, Inc. filed its definitive proxy statement (DEF 14A) on May 21, 2024, for its annual meeting of stockholders. The filing details information requi
Jaguar Health, Inc. Announces Special Meeting of Stockholders to Vote on Reverse Stock Split and Share Issuance — Mar 15, 2024 Risk: medium
Jaguar Health, Inc. (JAGX) filed a Proxy Statement (DEF 14A) with the SEC on March 15, 2024. Jaguar Health, Inc. is holding a Special Meeting of Stockholders on

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX